POINT 1 Study

Developer: Parallel 6, Inc.

App Size: 40.6 MB

Release Date: 2017-09-27

Price: FREE

6 Ratings

Category:

Medical

Size:

40.6 MB

Download on the App Store

Screenshots for App

iPhone

iPad

More Screenshots for iPad

"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.

The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."

POINT 1 Study 0.3.26

Version History

This app has been updated by Apple to use the latest Apple signing certificate.1. Removed bluetooth option for Glucometer reading transfer2. Added logic into the app where if a Glucose reading of less than 70mg/dl (Hypoglycemic Event), it automatically redirects you to symptom reporting screens.

~Parallel 6, Inc.

More Information about: POINT 1 Study

Price: FREE

Version: 0.3.26

Compatibility: Requires iOS 9 Or Later

Bundel Id: com.parallel6.mannkindafrezzapatient

Size: 40.6 MB

Genre: Medical

Release Date: 2017-09-27

Content Rating: 12+

Developer: Parallel 6, Inc.

Language: English -

All Apps & Games Developed by: Parallel 6, Inc.